Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: ixabepilone|DRUG: ixabepilone
Sponsor: Hellenic Cooperative Oncology Group